2016 Hematological Malignancies
Efficacy and Tolerability of ABVD HL patients >60y (E2496; n=45)
5-year FFS 53% Bleomycin lung toxicity in 24% (18% died)
Log-rank two sided P = 0.99
Made with FlippingBook
Efficacy and Tolerability of ABVD HL patients >60y (E2496; n=45)
5-year FFS 53% Bleomycin lung toxicity in 24% (18% died)
Log-rank two sided P = 0.99
Made with FlippingBook